In alignment with these results, our analysis confirmed that patients exhibiting high RPS6KC1 levels coupled with a Gleason score of 9, or those with low to medium RPS6KC1 levels and a Gleason score of 7, were associated with poor prognosis in PCa samples, according to TCGA data. Here, RPS6KC1 is linked to posterior cortical atrophy.